Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

C. Camps; B. Massuti; A. Jimenez; I. Maestu; R.G. Gómez; D. Isla; J.L. González; D. Almenar; A. Blasco; R. Rosell; A. Carrato; N. Vinolas; N. Batista; C. García Giron; A. Galán; M. López; R. Blanco; M. Provencio; P. Diz; E. and Spanish Lung Cancer Group Felip

doi:10.1093/annonc/mdj115

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

C. Camps, B. Massuti, A. Jimenez, I. Maestu, R.G. Gómez, D. Isla, J.L. González, D. Almenar, A. Blasco, R. Rosell, A. Carrato, N. Vinolas, N. Batista, C. García Giron, A. Galán, M. López, R. Blanco, M. Provencio, P. Diz, E. and Spanish Lung Cancer Group Felip

Department of Medicine

Research output: Contribution to journal › Article › Research

121 Citations (Scopus)

Original language	English
Pages (from-to)	467-472
Journal	Annals of Oncology
Volume	17
Issue number	3
DOIs	https://doi.org/10.1093/annonc/mdj115
Publication status	Published - 1 Mar 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdj115

Cite this

Camps, C., Massuti, B., Jimenez, A., Maestu, I., Gómez, R. G., Isla, D., González, J. L., Almenar, D., Blasco, A., Rosell, R., Carrato, A., Vinolas, N., Batista, N., García Giron, C., Galán, A., López, M., Blanco, R., Provencio, M., Diz, P., & Felip, E. A. S. L. C. G. (2006). Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial. Annals of Oncology, 17(3), 467-472. https://doi.org/10.1093/annonc/mdj115

@article{d349a3a8f62c471d861a4bea0c34ca60,

title = "Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial",

author = "C. Camps and B. Massuti and A. Jimenez and I. Maestu and R.G. G{\'o}mez and D. Isla and J.L. Gonz{\'a}lez and D. Almenar and A. Blasco and R. Rosell and A. Carrato and N. Vinolas and N. Batista and {Garc{\'i}a Giron}, C. and A. Gal{\'a}n and M. L{\'o}pez and R. Blanco and M. Provencio and P. Diz and Felip, {E. and Spanish Lung Cancer Group}",

year = "2006",

month = mar,

day = "1",

doi = "10.1093/annonc/mdj115",

language = "English",

volume = "17",

pages = "467--472",

number = "3",

}

Camps, C, Massuti, B, Jimenez, A, Maestu, I, Gómez, RG, Isla, D, González, JL, Almenar, D, Blasco, A, Rosell, R, Carrato, A, Vinolas, N, Batista, N, García Giron, C, Galán, A, López, M, Blanco, R, Provencio, M, Diz, P & Felip, EASLCG 2006, 'Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial', Annals of Oncology, vol. 17, no. 3, pp. 467-472. https://doi.org/10.1093/annonc/mdj115

TY - JOUR

T1 - Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

AU - Camps, C.

AU - Massuti, B.

AU - Jimenez, A.

AU - Maestu, I.

AU - Gómez, R.G.

AU - Isla, D.

AU - González, J.L.

AU - Almenar, D.

AU - Blasco, A.

AU - Rosell, R.

AU - Carrato, A.

AU - Vinolas, N.

AU - Batista, N.

AU - García Giron, C.

AU - Galán, A.

AU - López, M.

AU - Blanco, R.

AU - Provencio, M.

AU - Diz, P.

AU - Felip, E. and Spanish Lung Cancer Group

PY - 2006/3/1

Y1 - 2006/3/1

U2 - 10.1093/annonc/mdj115

DO - 10.1093/annonc/mdj115

M3 - Article

VL - 17

SP - 467

EP - 472

IS - 3

ER -